文献速递肝病消化道肿瘤与早癌

美国年轻成人肝细胞癌发病率正在下降

Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-04-28

该研究基于美国监测、流行病学和最终结果(SEER)项目1992至2015年癌症登记数据,分析肝细胞癌(HCC)年龄标化发病率随年龄、性别和种族/民族的变化趋势。HCC发病率在1992至2010年间每年增长4.8%,之后趋于平稳;但自2000年代中期起,年轻和中年成人(无论性别、种族/民族)的发病率下降,40至49岁人群每年下降6.2%,50至59岁人群每年下降10.3%。

要点

  • 1992至2010年HCC发病率每年增长4.8%,之后趋于平稳(年度百分比变化-0.7,95%CI -2.0至0.7)。
  • 2000年代中期起,年轻和中年成人(所有性别和种族/民族)HCC发病率下降。
  • 40至49岁人群每年下降6.2%,50至59岁人群每年下降10.3%;中年黑人自2012年起每年下降17.2%。

核心结论

  • 基于SEER 1992至2015年数据分析,美国年轻和中年成人HCC发病率下降,与性别、种族或民族无关;当前发病率下降能否降低未来HCC负担尚不清楚。

研究设计与样本

  • 基于美国监测、流行病学和最终结果(SEER)项目癌症登记数据(1992至2015年)计算年龄标化HCC发病率,按10岁年龄组分层,并使用连接点回归量化总体及按性别、种族/民族分层的趋势幅度和方向。

主要发现

  • HCC发病率从1992至2010年每年增长4.8%(从每10万人4.1例增至9.4例),之后趋于平稳(年度百分比变化-0.7,95%CI -2.0至0.7)。
  • 60岁及以上人群HCC发病率在所有种族/民族组中持续上升,但70至79岁亚洲/太平洋岛民除外。
  • 年轻和中年成人HCC发病率自2000年代中期起下降,40至49岁人群每年下降6.2%,50至59岁人群每年下降10.3%。
  • 中年黑人自2012年起HCC发病率每年下降17.2%,降幅大于同年龄其他种族/民族组。

关键数值与推荐

  • HCC发病率年度百分比变化:1992至2010年为每年增长4.8%;之后为-0.7(95%CI -2.0至0.7)。
  • 40至49岁人群HCC发病率每年下降6.2%;50至59岁人群每年下降10.3%。
  • 中年黑人自2012年起HCC发病率每年下降17.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Incidence rates for hepatocellular carcinoma (HCC) increased rapidly in the United States since the 1990s, but have plateaued or started to decrease in other industrialized countries. It unclear if and when a similar trend will be observed in the United States. We examined trends in HCC incidence rates in the United States by age, sex, and race/ethnicity of patients. METHODS: We calculated age-adjusted HCC incidence rates using data from the Surveillance, Epidemiology, and End Results program of cancer registries from 1992 through 2015. We estimated incidence rates by 10-year age group and used joinpoint regression to quantify the magnitude and direction of trends, overall and by sex and race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, and Asian/Pacific Islander). RESULTS: HCC incidence increased by 4.8% per year from 1992 through 2010 (from 4.1 per 100,000 to 9.4 per 100,000) but then started to plateau (annual percentage change, -0.7; 95% CI, -2.0 to 0.7). Incidence rates steadily increased among persons 60 years or older in all racial/ethnic groups except Asian/Pacific Islanders 70 to 79 years old. In contrast, incidence rates decreased in younger and middle-aged adults, in men and women of all races/ethnicities, beginning in the mid-2000s. Rates decreased by 6.2% per year in persons 40 to 49 years old and by 10.3% per year in persons 50 to 59 years old. Annual decreases in incidence were larger among middle-aged blacks (17.2% decrease per year since 2012) compared with adults of the same age in other racial/ethnic groups. CONCLUSIONS: In an analysis of data from the Surveillance, Epidemiology, and End Results program of cancer registries from 1992 through 2015, we found the incidence of HCC to be decreasing among younger and middle-aged adults in the United States, regardless of sex, race, or ethnicity. It is unclear whether current decreases in incidence will reduce the burden of HCC in the future.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Rich NE, Yopp AC, Singal AG, et al. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States. Clin Gastroenterol Hepatol. 2019. PMID: 31042582. doi:10.1016/j.cgh.2019.04.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。